TTK Healthcare Limited has informed the Exchange regarding 'Annual Report for the FY 2024-25'.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TTK Healthcare has submitted its 67th Annual Report for FY 2024-25, with the Annual General Meeting scheduled for July 25, 2025 at 12:00 noon via video conferencing. For FY24-25, revenue from continuing operations rose to Rs.872.75 crores from Rs.815.40 crores, a growth of about 7%. Profit after tax grew roughly 30% to Rs.81.66 crores, up from Rs.62.84 crores in the previous year. EBITDA expanded to Rs.119.98 crores from Rs.99.93 crores, a jump of about 20%. Both PAT and PBT figures include exceptional items, as flagged in the report. The Board has recommended a 100% dividend (Rs.10 per share of Rs.10 face value), unchanged from the prior year. Shareholders will also consider the appointment of a new secretarial auditor for five years and ratification of the cost auditor's remuneration.
Strong year for shareholders with a 30% jump in profits and sustained 100% dividend. The presence of exceptional items in the profit numbers means core operating performance may be more modest than headline PAT suggests, warranting a closer look at the report's notes.